在JYNNEOS疫苗接种后,HIV-1感染个体的泛天花特异性T细胞反应
Marta Sisteré-Oró1, Juan Du2, Diana D J Wortmann1
1Infection Biology Laboratory, Department of Medicine and Life Sciences, Universitat Pompeu Fabra (UPF), Barcelona, Spain.
对于患有人类免疫缺陷病毒 (HIV) 的人来说,JYNNEOS天花疫苗是安全的. 皮内接种疫苗比皮下接种更有效,特别是对于那些CD4计数较低的人来说,用提升剂.
科学领域:
- 免疫学 免疫学 免疫学
- 病毒学 病毒学
- 疫苗学 疫苗学 疫苗学
背景情况:
- 目前的病毒疫情不成比例地影响了人类免疫缺陷病毒 (HIV) 的个体.
- 了解这种人群中的疫苗有效性对于公共卫生战略至关重要.
研究的目的:
- 为了评估HIV-1感染者在JYNNEOS疫苗接种后的泛天花特异性T细胞反应.
- 为了比较皮内膜 (i.d.) 与皮下 (s.c.) 疫苗接种途径相比,并评估是否需要强剂.
主要方法:
- 一组HIV-1感染个体接受了JYNNEOS疫苗.
- 分析了T细胞反应,包括多功能性和肠回归标志物表达.
- 接种疫苗的路线 (已知) 并且考虑了CD4 T细胞计数和CD4 T细胞计数.
主要成果:
- 在HIV-1感染的个体中,JYNNEOS疫苗是安全的.
- 剂量节省的身份证. 疫苗接种优于s.c.疫苗接种,增强T细胞多功能性和α4β7整体蛋白表达.
- 具有CD4 T细胞计数≤500/mm3的个体需要进行强剂疫苗接种,以获得有效的T细胞反应.
结论:
- 皮内JYNNEOS疫苗接种是HIV-1感染个体的安全有效策略.
- 对于具有较低CD4计数的个体,需要进行强剂疫苗接种,以获得最佳的T细胞反应.
- 增强剂后的Th1反应的大小与CD4T细胞计数相关,这表明免疫复合是关键.
更多相关视频
08:04Development of an IFN-γ ELISpot Assay to Assess Varicella-Zoster Virus-specific Cell-mediated Immunity Following Umbilical Cord Blood Transplantation
Published on: July 9, 2014
08:13Optimized Interferon-gamma ELISpot Assay to Measure T Cell Responses in the Guinea Pig Model after Vaccination
Published on: January 20, 2019
相关概念视频
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Cell-mediated Immune Responses
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Humoral Immune Responses
Vaccinations
Antigens Involved in Adaptive Immunity
Complete Antigens
Complete antigens possess both immunogenicity and...
